Regulatory Affairs

To ensure products enter their intended markets without problems, we have regulatory affairs teams specialised in the requirements for New Zealand, Australia, Africa, South Africa, Asia, Europe, the Middle East and North, Central and South America. The teams work closely together, which gives us the benefit of global thinking combined with local knowledge.

The primary focus for our regulatory affairs personnel is the preparation and maintenance of product registration dossiers. To support product registrations, we also arrange application for and maintenance of the company's trademarks. Douglas Pharmaceuticals currently owns a portfolio of more than 210 trademarks.

Export partners can confidently trust our management of regulatory affairs because we apply the International Committee on Harmonisation (ICH) and Asean guidelines for pharmaceutical development.

Douglas products and/or developments are currently registered or awaiting registration in the following countries: Argentina, Australia, Austria, Bangladesh, Belgium, Botswana, Cambodia, Canada, Chile, Czech Republic, Colombia, Denmark, El Salvador, Estonia, Finland, France, GCC, Germany, Greece, Hong Kong, Hungary, Indonesia, Iran, Ireland, Israel, Italy, Korea, Latvia, Lithuania, Luxembourg, Malaysia, Malta, Mexico, Netherlands, New Zealand, Norway, Pakistan, Philippines, Portugal, Romania, Singapore, Slovakia, Slovenia, South Africa, Spain, Sri Lanka, Sweden, Switzerland, Taiwan, Thailand, Turkey, UAE, United Kingdom, Uruguay, USA, Venezuela and Vietnam